6-Methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)-2-pyridinyl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydro-3-pyridinecarboxamide(CAS: 848141-11-7)

This compound is subject to regulation under the Globally Harmonized System (GHS) of Classification and Labelling of Chemicals, REACH regulations, and FDA/EPA guidelines. It is classified as a pharmaceutical intermediate and should comply with specific handling, storage, and disposal requirements outlined in these frameworks.

There are alternative reagents and synthetic approaches that can be used as substitutes. For instance, using 6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-({5-(methylsulfonyl)-2-pyridinyl}methyl)picolinamide as a starting material can offer a more straightforward synthesis route. Additionally, isomers and analogs can be explored for similar applications.

The market trend for this compound is driven by its application in pharmaceuticals and agrochemicals. Research is focusing on its potential as an active pharmaceutical ingredient. Market dynamics show increasing demand from the pharmaceutical industry, with a focus on developing new therapies and treatments.

Waste containing this compound should be collected and disposed of according to hazardous waste regulations. Incineration is a common method for disposal, ensuring complete combustion to minimize environmental impact. Professional waste disposal services should be utilized to ensure compliance with environmental protection standards and regulations.